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Abstract
Background: Osteoarthritis (OA) is an degenerative disease characterized by chronic joint pain. Complementary
and alternative treatment such as acupuncture have been utilized to alleviate pain. The objective of this study was
to investigate the analgesic mechanisms of electroacupuncture (EA) in the collagenase-induced osteoarthritis (CIOA)
rat model.
Methods: Four weeks after inducing CIOA by injecting collagenase solution into the left knee of 5-week-old male
Sprague-Dawley rats, 2 Hz and 100 Hz EA on Zusanli (ST 36) was performed. The analgesic effect of EA was
evaluated by the tail flick latency (TFL) and paw pressure threshold (PPT) tests. To investigate the analgesic
mechanism, serotonergic and muscarinic cholinergic receptor agonists and antagonists were injected 20 min prior
to EA and the resultant changes were evaluated by the TFL and PPT tests.
Results: EA on Zusanli (ST 36) demonstrated an analgesic effect in the CIOA rat model. The 2 Hz EA treatment
showed a significantly greater analgesic effect than the 100 Hz treatment. The analgesic effect of 2 Hz EA was not
strengthened by 5-HT1, 5-HT2, 5-HT3, and muscarinic cholinergic receptor agonist pretreatment, was blocked by 5-
HT1, 5-HT3, and muscarinic cholinergic receptor antagonist pretreatment, but not blocked by 5-HT2 receptor
antagonist pretreatment.
Conclusions: In the CIOA rat model, EA on Zusanli (ST 36) exhibited analgesic effects, and 2 Hz EA resulted in a
significantly greater analgesic effect than 100 Hz EA. The analgesic effect of 2 Hz EA was reduced by pretreatment
of 5-HT1 receptor, 5-HT3 receptor and muscarinic cholinergic receptor antagonists.
Keywords: Collagenase-induced osteoarthritis, Electroacupuncture, Analgesic effect, Analgesic mechanism,
Serotonergic receptor, Cholinergic receptor
Background
Osteoarthritis (OA) is one of the most prevalent chronic
joint disease at present. It is characterized by loss of ar-
ticular cartilage, osteophyte formation, subchondral bone
change, and synovitis [1]. OA has varying effects on the
individual and on society. OA patients, especially elderly
patients, experience symptoms every day, resulting in a
lower quality of life. From a societal perspective, the
increasing financial costs of treatment and management of
OA are a challenging problem. The healthcare costs associ-
ated with OA in the USA exceed $60 billion annually and
can increase up to $185.5 billion [2], demonstrating the im-
portance of more effective OA treatments. To date, as
complementary and alternative options for various treat-
ment modalities including medications, patient education,
exercise and physical therapy, non-pharmacological alter-
native modailities such as acupuncture and electroacu-
puncture (EA) have been administered [3, 4].
Acupuncture has been widely used to alleviate many
types of pain, particularly chronic pain [5]. Human and
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animal study models have shown that acupuncture-
induced analgesia is mediated through various neurotrans-
mitters, modulators, and related factors including β-
endorphin, enkephalin, endomorphin, and dynorphin [6].
The analgesic effects of EA have also been established
through many studies. Researchers have conducted clin-
ical trials and animal model studies on neuropathic pain
and collagen-induced arthritis and demonstrated the de-
scending modulation of nociceptive processing [7–11].
The analgesic effects and its adrenergic or opioidergic
mechanisms of EA in CIOA in vivo study was reported
[12, 13], but the serotonergic and cholinergic roles in
EA analgesia have not been fully clarified. Current study
was designed to investigate which receptors agonists and
antagonists were involved in the analgesic effect of EA
in CIOA in vivo model.
Methods
Animals
Five-week-old male Sprague-Dawley rats weighing
200 mg were obtained from Samtaco (Osan, Korea) and
housed under controlled temperature (22 ± 1°C), humid-
ity (55 ± 5 %), and 1:1 light-dark cycle (light from 6 AM
to 6 PM). All animals had free access to food and water.
All experiments were approved and conducted under
the guidelines of the International Association for the
Study of Pain and the Institutional Animal Care and Use
Committee of Kyung Hee University [14].
Induction of collagenase-induced osteoarthritis
After one week of adaptation to the laboratory conditions,
intra-articular collagenase injection was performed; 0.05 ml
of 4 mg/ml collagenase solution (Clostridium histolyticum,
type II; enzyme activity 425 U/mg) was injected into the left
knee of all rats. Four days after the first injection, a booster
injection was administered. The gross articular manifesta-
tions were assessed and histopathological and serological
analyses were performed according to previous CIOA stud-
ies [12, 13]. Briefly, the severity of stiffness was scored on a
scale of 0–4 in the affected articulation as a reflection of
edema and movement impairment. Two independent
examiners assessed gross articular manifestations in a blind
manner. At the end of the fourth week, the rats were sacri-
ficed for histopathological analysis. Six parameters, i.e.,
including loss of the superficial layer, erosion of cartilage,
fibrillation and/or fissures, disorganization of chondrocytes,
loss of chondrocytes, and cluster formation, were evaluated
for the histological analysis. Serum from each subject was
prepared for the measurement of COX-1, COX-2, PGE2
activity (data not shown).
Behavioral test
After four weeks of induction of CIOA and adaptation
in the laboratory room conditions, tail flick latency
(TFL) and paw pressure threshold (PPT) tests were per-
formed at baseline, 10, 20, 30, 45, 60, and 90 min after
initiation of EA.
To evaluate the analgesic effect on the thermal stimuli,
the TFL test was performed using the tail flick unit (Ugo
Basile Model 7360, Comrio, Italy) [15]. The rat was fixed
in a 5.3 cm diameter × 15 cm length holder and the
proximal third portion of six parts of the tail was laid on
the 50-W infrared light bulb. The time lapse between
the onset of irradiation and the flick of the tail was mea-
sured on the unit. The mean time was calculated after
three continuous measurements and expressed in sec-
onds. TFL test was performed at baseline, 10, 20, 30, 45,
60, and 90 min after initiation of EA. The time of irradi-
ation was limited at 20 s and the portion of the tail ex-
posed to the light bulb was shifted to prevent thermal
injury. The change of TFL was calculated as a percent-
age of change of tail flick latency. The increase in the de-
gree of TFL change represents the analgesic effect on
the thermal stimuli.
The degree of TFL change ð%Þ ¼ post:EA TFLbaseline TFL
baseline TFL
 100
For evaluation of the analgesic effect on the mechan-
ical stimuli, a PPT test was performed [16]. Rats were
gently held in the cap and the algesiometer device
(modified Randall-Selitto test; Ugo Basile, Comerio,
Italy) was applied to the dorsal surface of the hind paw.
The mechanical device increased the pressure by gram
units until the rat withdrew its paw. The mean pressure
was calculated after three consecutive measurements
and expressed in grams. With 10-s intervals, the PPT
test was performed at baseline, 10, 20, 30, 45, 60, and
90 min after initiation of EA. The upper limit of pres-
sure was 250g to prevent tissue damage. The increase in
the mean pressure represents the analgesic effect on the
mechanical stimuli.
Electroacupuncture treatment
After four weeks of induction of CIOA and adaptation to
the laboratory condition, EA was performed into Zusanli
(ST36), located laterally from tibial tuberosity and caudally
below knee joint on the anterior tibialis muscle. The
Zusanli acupoint is generally used to alleviate pain in clin-
ical trials and animal studies [10–13, 17]. Two disposable
sterile stainless needles (0.25 mm diameter × 40 mm
length) were inserted into Zusanli (ST 36) and another
point 5 mm away from the selected point. The acupunc-
ture needle was inserted to the depth of 5 mm and stimu-
lated with a train pulse (0.3 ms, 0.07 mA) for 30 min by
an electrical stimulator (Nihon Kohden). At first, EA was
performed at 2 Hz and 100 Hz to compare analgesic
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effects at different frequencies. The frequency that showed
a better analgesic effect was selected when conducting
experiments on the analgesic mechanism of EA.
Pretreatment with agonists and antagonists
To investigate the analgesic mechanism, the 5-HT1 re-
ceptor agonist 8-OH-DPAT (8 ODT) and antagonist
spiroxatrine (SPROX), the 5-HT2 receptor agonist DOI
(DOI) and antagonist ketanserin (KTSRN), the 5-HT3
receptor agonist m-chlorophenyl-biguanide (mCLBG)
and antagonist ondansetron (ODSTN), and the muscar-
inic cholinergic receptor agonist neostigmine (NSTM)
and antagonist atropine (ATRP) were dissolved in sterile
10 % DMSO (dimethyl sulfoxide) and intraperitoneally
injected 20 min before EA.
Statistical analysis
All results were expressed in mean ± standard error of
mean. In nonparametric procedures, statistically signifi-
cant differences (p < 0.05) were determined by Fried-
man’s rank test followed by Dunnett’s post-hoc test
within a group, Mann–Whitney U test between two
groups, and Kruskal–Wallis ANOVA followed by Dun-
nett’s post-hoc test among groups.
Results
The analgesic effect of EA and comparison according to
latency (2, 100 Hz)
The effects of EA at 2 Hz and 100 Hz in the CIOA rat
model are shown in Fig. 1. The degree of TFL change in-
creased during 10–60 min and peaked at 30 min after
initiation of EA. Both EA treatment groups showed sta-
tistically significant differences compared with the no
treatment group (n = 10). The 2 Hz EA treatment group
(n = 10) showed a significantly greater TFL change than
the 100 Hz EA treatment group (n = 10) (Fig. 1a). PPT
also increased during 10–60 min and peaked at 30 min
after initiation of EA. Both EA treatment groups showed
significant differences compared with the no treatment
group (n = 10). Between the two EA treatment groups,
the 2 Hz EA treatment group (n = 10) showed a
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Fig. 1 The effects of EA at 2 Hz and 100 Hz in the CIOA rat model assessed by TFL (a) and PPT (b). 2 Hz EA treatment group (2 Hz-EA, n = 10),
100 Hz EA treatment group (100 Hz-EA, n = 10) and no treatment group (None-Tx, n = 10). $p < 0.05, $$p < 0.01, $$$ p < 0.001: compared with
None-Tx; **p < 0.01, ***p < 0.001: compared with None-Tx; #p < 0.05, ##p < 0.01, ###p < 0.001: compared with 100 Hz-EA
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significantly higher PPT than the 100 Hz EA treatment
group (n = 10) (Fig. 1b).
The 5-HT1 receptor Involvement of EA-induced analgesia
The effects of the 5-HT1 receptor agonist 8-ODT and
antagonist SPROX on the analgesia induced by 2 Hz
EA in the CIOA rat model are shown in Fig. 2. In
the TFL test, there were no significant differences be-
tween the EA + 8 ODT group (n = 10) and the EA +
DMSO group (n = 10). However, TFL increases in-
duced by ST36 EA were significantly suppressed by
SPROX pretreatment (n=10) 10–90 min after initi-
ation of EA (Fig. 2a). In the PPT test, there were no
significant differences between the EA + 8 ODT
group (n = 10) and the EA + DMSO group (n = 10).
However, PPT increases induced by ST36 EA were
significantly suppressed by SPROX pretreatment
(n=10) 10–90 min after initiation of EA (Fig. 2b).
The 5-HT2 receptor Involvement of EA-induced analgesia
The effects of the 5-HT2 receptor agonist DOI and an-
tagonist KTSRN on the analgesia induced by 2 Hz EA in
the CIOA rat model are shown in Fig. 3. In the TFL test,
there were no significant differences between the EA +
DOI group (n = 10), the EA + KTSRN group, and the
EA + DMSO group (n = 10) (Fig. 3a). In the PPT test,
there were also no significant differences between the
EA + DOI group (n = 10), the EA + KTSRN group, and
the EA + DMSO group (n = 10) (Fig. 3b).
The 5-HT3 receptor Involvement of EA-induced analgesia
The effects of the 5-HT3 receptor agonist mCLBG and
antagonist ODSTN on the analgesia induced by 2 Hz
EA in the CIOA rat model are shown in Fig. 4. In the
TFL test, there were no significant differences between
the EA + mCLBG group (n = 10) and the EA + DMSO
group (n = 10) except 30 min after initiation of EA.
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Fig. 2 The effects of pretreatment of 5-HT1 receptor agonist (8-OH-DPAT, EA+8 ODT, n = 10) and antagonist (spiroxatrine, EA+SPROX, n = 10) in
the CIOA rat treated by 2 Hz EA (EA+DMSO, n = 10) assessed by TFL (a) and PPT (b). Pretreatment with DMSO, 8 ODT, and SPROX was performed
20 min before 2 Hz EA. *p < 0.05, **p < 0.01, ***p < 0.001: compared with EA+DMSO
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However, TFL increases induced by ST36 EA were sig-
nificantly suppressed by ODSTN pretreatment (n=10)
20–90 min after initiation of EA (Fig. 4a). In the PPT
test, there were no significant differences between the
EA + mCLBG group (n = 10) and the EA + DMSO
group (n = 10) except 30 min after initiation of EA.
However, PPT increases induced by ST36 EA were sig-
nificantly suppressed by ODSTN pretreatment (n=10)
20–90 min after initiation of EA (Fig. 4b).
The muscarinic cholinergic receptor Involvement of
EA-induced analgesia
The effects of the muscarinic cholinergic receptor agon-
ist NSTM and antagonist ATRP on the analgesia in-
duced by 2 Hz EA in the CIOA rat model are shown in
Fig. 5. In the TFL test, there were no significant differ-
ences between the EA + NSTM group (n = 10) and the
EA + DMSO group (n = 10). However, TFL increases in-
duced by ST36 EA were significantly suppressed by
ATRP pretreatment (n = 10) 10–90 min after initiation
of EA (Fig. 5a). In the PPT test, there were no significant
differences between the EA + NSTM group (n=10) and
the EA + DMSO group (n=10). However, PPT increases
induced by ST36 EA were suppressed by ATRP pretreat-
ment (n=10) 10–90 min after initiation of EA (Fig. 5b).
The involvement of each receptor agonists and antagonists
in EA-induced analgesia
The effects of each receptor agonist and antagonist
on the analgesia in the CIOA rat model are shown in
Fig. 6. In both the TFL and PPT test, there were no
significant differences between each receptor agonist
and antagonist group except the None-Tx + mCLBG
group at 30 min after measurement (Fig. 6).
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Fig. 3 The effects of pretreatment of 5-HT2 receptor agonist (DOI, EA+DOI, n = 10) and antagonist (ketanserin, EA+KTSRN, n = 10) in the CIOA rat
treated by 2 Hz EA (EA+DMSO, n = 10) assessed by TFL (a) and PPT (b). Pretreatment with DMSO, DOI, and KTSRN was performed 20 min before
2 Hz EA
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Discussion
OA is the most common degenerative joint disorder
characterized by the progressive erosion of articular car-
tilage. The aching pain may worsen with use, and can be
accompanied by morning stiffness, crepitus contributes
to limited articular function and deteriorated quality of
life [18]. The pathogenesis of OA is not entirely estab-
lished, but is likely related to inflammatory cytokines
that mediate cartilage destruction [19].
The current standard care for OA focuses on alleviating
pain and managing symptoms. For the pharmacological
treatment options, non-steroidal anti-inflammatory drugs
(NSAIDs) have been considered as the primary therapy
for OA [20]. Despite their universal administration for
pain relief in osteoarthritis patients, the long term use of
NSAIDs is controversial due to the gastrointestinal disor-
ders and cardiovascular events related to their safety pro-
file [21, 22]. The demands of osteoarthritis patients for
non-pharmacologic therapies, especially acupuncture,
have increased due to failure to alleviate pain and improve
articular function.
EA has been used to treat a diverse range of painful con-
ditions. Previous research has suggested a relationship be-
tween pain modulatory mechanisms and acupuncture
analgesia, focusing on the role of transmitters and modu-
lators [23]. The EA analgesia is initiated by needles trig-
gering stimulation of afferent nerves and related with
systemic activation of a variety of bioactive chemicals
through peripheral, spinal and supraspinal mechanisms
[24]. Research on EA analgesia induction and recovery
profiles has demonstrated the possible involvement of
humoral factors [25]. Several studies have been performed
to prove the analgesic effect and mechanism of EA in vari-
ous animal models, considering EA stimulation parame-
ters such as frequency, intensity, and wave form [9–11].
However, there are limited studies on EA in CIOA model.
Various methods, including surgical procedures and
intra-articular injections, can be used to induce OA.
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Fig. 4 The effects of preatreatment of 5-HT3 receptor agonist (m-chlorophenyl-biguanide, EA+mCLBG, n = 10) and antagonist (ondansetron, EA+ODSTN,
n = 10) in the CIOA rat treated by 2 Hz EA (EA+DMSO, n = 10) assessed by TFL (a) and PPT (b). Pretreatment with DMSO, mCLBG, and
ODSTN was performed 20 min before 2 Hz EA. #p < 0.05, **p < 0.01, ***p < 0.001: compared with EA+DMSO
Seo et al. BMC Complementary and Alternative Medicine  (2016) 16:212 Page 6 of 11
Intra-articular injection with chemical substances can be
more conveniently performed in many studies because
surgical procedures are complicated and take a longer
period of time to induce degeneration [26]. When select-
ing a chemical substance, some studies have used papain
but its use is limited by both its unclear mechanism of
action and large dose requirement (4–12 mg) [27]. In
contrast, a previous study demonstrated that CIOA was
characterized by severe degenerative cartilage lesions,
sclerosis of the subchondral bone below the cartilage
erosions, osteophyte formation, and consequent deform-
ity [28]. Other research showed that in the progression
of OA, a larger amount of collagenase was detected [29]
and cytokines stimulated the production of collagenase
as a proteolytic enzyme [30]. In this regard, collagenase
was considered to be appropriate to induce OA in rats
that would be similar to the clinical manifestations in
human version of OA.
In order to determine the proper time to conduct ex-
periments with the CIOA model, the gross articular
manifestations and histopathological and serological fea-
tures were evaluated. In accordance with the results of
previous studies, most of the osteoarthritic clinical and
histopathological features were observed from 4 weeks
after first collagenase injection. These features included
altered pain-related behaviors, gross articular manifesta-
tions, cartilage-destructive features and serological bio-
marker activities [12, 13].
TFL and PPT tests are commonly used to evaluate the
degree of nociception through the change of animal be-
havior. TFL is focused on the thermal stimuli and PPT
is focused on the mechanical stimuli. Pain in OA is asso-
ciated with thermal and mechanical hyperalgesia and af-
fected by local mechanical and thermal factors [31]. TFL
and PPT tests are appropriate to evaluate analgesic ef-
fects on thermal and mechanical stimuli in the CIOA, in
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Fig. 5 The effects of pretreatment of muscarinic cholinergic receptor agonist (neostigmine, EA+NSTM, n = 10) and antagonist (atropine,
EA+ATRP, n = 10) in the CIOA rat treated by 2 Hz EA (EA+DMSO, n = 10) assessed by TFL (a) and PPT (b). DMSO, NSTM, and ATRP were
pretreated 20 min before 2 Hz EA. *p < 0.05, **p < 0.01, ***p < 0.001: compared with EA+DMSO
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accordance with other painful condition experiments
[32]. However, there are few existing studies that have
conducted TFL and PPT at the same time and showed
positive results in the CIOA.
The acupoint Zusanli (ST 36) is traditionally used to
reduce pain. Previous studies showed that EA on Zusanli
(ST 36) led to analgesia using the tail flick method and
c-Fos expression in the brain [33], and its effect was re-
lated to peripheral nerve receptors and biomarkers like
β-endorphin and cortisol [34, 35].
Our results demonstrated that both 2 Hz and
100 Hz EA showed analgesic effect, evidenced in the
TFL and PPT tests. The 2 Hz EA more effectively re-
lieved thermal and mechanical hyperalgesia than the
100 Hz EA, in accordance with the results of previ-
ous studies. It has been shown that low-frequency EA
is more effective for nociceptive pain whereas high-
frequency EA is more effective for neurogenic pain
[36]. Recent studies also showed that 2 Hz EA pro-
vides better and longer-lasting analgesic effects on
mechanical allodynia [37, 38]. These results suggest
that low-frequency EA is appropriate for the treat-
ment of OA related pain.
In order to investigate the analgesic mechanism of EA,
we conducted experiments with serotonergic and mus-
carinic cholinergic receptor agonists and antagonists.
With respect to the serotonergic mechanism, our study
showed that the analgesic effect of 2 Hz EA was not
strengthened by the 5-HT1, 5-HT2, and 5-HT3 receptor
agonists. In experiments with antagonists, the analgesic
effect of 2 Hz EA was blocked by the 5-HT1 and 5-HT3
receptor antagonists, but not blocked by the 5-HT2 re-
ceptor antagonist. These results suggest that the 5-HT1
and 5-HT3 receptors partially mediate the analgesia in-
duced by 2 Hz EA in the CIOA rat model. Ryu et al.
[10] conducted experiments on the analgesic effects and
mechanism of 2 Hz EA in the collagen-induced arthritis
(CIA) model using 5-HT1A, 5-HT1B, and 5-HT4 recep-
tor antagonists, and demonstrated that the analgesic ef-
fect of EA was blocked by 5-HT1A, 5-HT1B, and 5-HT4
receptor antagonists. Baek et al. [39] conducted experi-
ments on the analgesic effects and mechanism of 2 Hz
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Fig. 6 The effects of each receptor agonists and antagonists on the pain threshold in CIOA rat model assessed by TFL (a) and PPT (b). *p < 0.05:
compared with each group
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EA in a CIA model using 5-HT1A, 5-HT2, and 5-HT3
receptor agonists and antagonists, and demonstrated
that the analgesic effect of EA was blocked by the 5-
HT1A and 5-HT3 receptor antagonists, but not blocked
by the 5-HT2 receptor antagonist. Chang et al. [40]
demonstrated that 5-HT1A and 5-HT3 receptor antag-
onist blocked EA analgesia at three different frequencies
(2, 10, and 100 Hz) and Kim et al. [41] suggested that 5-
HT1A and 5-HT3 receptors had important roles in me-
diating the relieving effect 2 Hz EA on cold allodynia. In
this regard, 2 Hz EA induces an analgesic effect through
5-HT1 and 5-HT3 receptors.
With respect to the cholinergic mechanism, our study
showed that the analgesic effect of 2 Hz EA was not
strengthened by the muscarinic cholinergic receptor
agonist and blocked by muscarinic cholinergic receptor
antagonist. These results suggest that the muscarinic
cholinergic receptor partially mediates the analgesia in-
duced by 2 Hz EA in the CIOA rat model. Baek et al.
[39] also conducted experiments on the analgesic effects
and mechanism of 2 Hz EA in the CIA model using a
muscarinic cholinergic receptor agonist and antagonist,
and demonstrated that the analgesic effect of EA was
blocked by the muscarinic cholinergic receptor antagon-
ist. Park et al. [42] studied the effects of 2 Hz EA on cold
and warm allodynia in a neuropathic rat model using
several muscarinic receptor antagonists and demon-
strated that spinal muscarinic receptors, especially M1
subtype, mediate the EA antiallodynia. In this regard,
2 Hz EA induces analgesic effect through muscarinic
cholinergic receptor.
Conflicting study results have been reported in the
role of the serotonergic agonists and antagonists them-
selves in pain modulatioin. McCleane et al. [43] sug-
gested that ondansetron could have an analgesic effect
in neuropathic pain in a double-blind study and Ali Z
et al. [44] showed that ondansetron reduced nociceptive
response in behavioral and electrophysiological studies.
Houde RW [45] showed the analgesic effectiveness of
narcotic agonists and antagonists. Takagi et al. [46] ex-
amined the effects of several serotonin (5-HT) antago-
nists on 2 Hz EA analgesia in tooth pulp stimulation rat
models and suggested that 5-HT1, except 5-HT1A; 5-
HT2, except 5-HT2A; and 5-HT3 receptors are positively
related to EA-induced analgesia.
The present study demonstrated that 5-HT antagonists
ODSN intraperitoneal pretreatment suppressed the ST-36
2Hz EA-induced analgesia but there was no significant TFL
and PPT changes when EA was not administered. It ap-
pears that 5-HT3 agonist mCLBG intraperitoneal pretreat-
ment increased pain thresholds assessed by TFL and PPT
not only in absence of EA treatment and also in ST-36 2Hz
EA. Ali Z et al. [44] demonstrated that intrathecal adminis-
tration of mCLBG increased the responsiveness of dorsal
horn neurons to noxious stimulation. Sasaki et al. [47] re-
ported that intrathecal 5-HT3 receptor agonist, 2-methyl-
5-HT mediates antinociception to chemical stimuli.
In summary of the results of our research and previous
studies, we speculate that the pain threshold-modulatory
effects of serotonergic agonists and antagonits could de-
pend on differences among the agonists, antagonists,
time of agonists and antagonits pretreatment, adminis-
trative maneuver (intraperitoneal or intrathecal), and the
type of pain models.
Considering limited knowledge on the therapeutical
active components of EA and the physiological reactions
followed by EA, restricted conclusive implication
whether 2 Hz EA induced analgesia was mediated by se-
rotonergic and cholinergic receptor mechanisms could
be made. Because current study did not perform a com-
parison with the effect of non-acupoint EA, further stud-
ies are needed to investigate the acupoint specific effects
of ST36 EA using various EA stimulation parameters in-
cluding frequency.
Conclusion
In summary, these observation suggest that 5-HT1, 5-
HT3 and muscarinic cholinergic receptors partially me-
diate the analgesic effects of EA in CIOA. These results
suggests that EA could be a potential option for the
relieving osteoarthritic pain.
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